trending Market Intelligence /marketintelligence/en/news-insights/trending/zj9lmwrqvgow6qjdfctfdw2 content esgSubNav
In This List

Atara Biotherapeutics starts $150M common stock offering

Blog

Insight Weekly: US inflation soars; real estate faces slowdown; megadeals drive tech M&A

Blog

Commercial Banking: June 22nd Edition

Blog

Understanding Loss Given Default A Review of Three Approaches

Blog

Insight Weekly: Path to net-zero; US manufacturing momentum; China's lithium M&A frenzy


Atara Biotherapeutics starts $150M common stock offering

Atara Biotherapeutics Inc. is selling $150 million of its common shares in an underwritten public offering.

The company also expects to grant the underwriters an option to buy up to an additional $22.5 million of common shares.

J.P. Morgan and Cowen are acting as joint book-running managers for the proposed offering.